Volitionrx (VNRX) Operating Expenses (2011 - 2025)

Volitionrx has reported Operating Expenses for 11 years, with the latest figure at $5.3 million in Q4 2025.

• For the quarter ending Q4 2025, Operating Expenses fell 11.85% year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2025 stood at $23.5 million (down 16.96% YoY), and the FY2025 full-year result was $23.5 million, down 16.96% from the prior year.
• Operating Expenses for Q4 2025 stood at $5.3 million, down from $5.7 million in the prior quarter.
• The five-year high for Operating Expenses was $9.8 million in Q2 2023, with the low at $5.3 million in Q4 2025.
• Historically, Operating Expenses has averaged $7.4 million across 5 years, with a median of $7.7 million in 2021.
• Annual changes were most pronounced in 2021 — Operating Expenses soared 68.43% — and 2024, when it slumped 33.52%.
• Volitionrx's Operating Expenses stood at $8.8 million in 2021, then retreated by 7.6% to $8.1 million in 2022, then gained by 10.51% to $9.0 million in 2023, then tumbled by 33.52% to $6.0 million in 2024, then fell by 11.85% to $5.3 million in 2025.
• The last three Operating Expenses figures came in at $5.3 million (Q4 2025), $5.7 million (Q3 2025), and $6.7 million (Q2 2025), per Business Quant data.